Skip to main content
Arctic Bioscience logo

Arctic Bioscience — Investor Relations & Filings

Ticker · ABS ISIN · NO0010859580 LEI · 549300Z2HW6I989Q2C78 OL Manufacturing
Open in API
Filings indexed 426 across all filing types
Latest filing 2026-05-27 Declaration of Voting R…
Country NO Norway
Listing OL ABS

About Arctic Bioscience

https://arctic-bioscience.com/

Arctic Bioscience is a biotechnology company that develops and commercializes pharmaceutical and nutraceutical products derived from marine membrane lipids. The company utilizes proprietary technology to extract bioactive compounds from herring roe, sourced from sustainable, MSC-certified fisheries. Its nutraceutical product line, marketed under the brand name Romega, consists of high-DHA Omega-3 phospholipid extracts. The pharmaceutical division is focused on developing a novel drug candidate for the treatment of mild-to-moderate psoriasis, aligning with its mission to create therapies for autoimmune disorders. The company's work is supported by extensive research and development to validate the efficacy of its marine-based ingredients.

Recent filings

Filing Released Lang Actions
Arctic Bioscience - Minutes of the Annual General Meeting - Attachment: 20260527_ABS_Minutes_from_Ordinary_General_Meeting.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 87% confidence The document is the official minutes and protocol from Arctic Bioscience’s ordinary general meeting held on 27 May 2026. It details agenda items, resolutions passed (including approval of the annual accounts, board member elections, auditor fees, and authorization for share capital increase), and provides the voting results (number of votes for/against, percentages) for each item. This aligns with "Declaration of Voting Results & Voting Rights Announcements (DVA)", which covers official results from shareholder votes at any general meeting. It is not merely a notice or proxy, nor a financial report. Hence, it should be classified as DVA.
2026-05-27 Norwegian Bokmål
Arctic Bioscience - Protokoll fra ordinær generalforsamling - Attachment: 20260527_ABS_Minutes_from_Ordinary_General_Meeting.pdf
AGM Information Classification · 82% confidence The document is the official minutes (protocol) from an ordinary general meeting (AGM) of Arctic Bioscience AS, detailing the meeting proceedings, resolutions passed, voting results for each agenda item, and approvals of annual accounts, board elections, and authorizations. This clearly constitutes materials and official records from an AGM rather than a standalone financial report, regulatory announcement, or simple voting-results memo. Therefore, it best fits the ‘AGM Information’ category (AGM-R).
2026-05-27 Norwegian Bokmål
Arctic Bioscience - Minutes of the Annual General Meeting
AGM Information Classification · 90% confidence The document is the official minutes from the company’s Annual General Meeting, detailing the agenda outcomes and the approved changes to the board of directors. Minutes and materials from AGMs fall under AGM Information (AGM-R).
2026-05-27 English
Arctic Bioscience - Protokoll fra ordinær generalforsamling
AGM Information Classification · 90% confidence The document is the official minutes (“protokoll”) of the ordinary general meeting held on May 27, 2026, and includes the materials and outcomes of the AGM (including board changes). This corresponds to AGM Information rather than a standalone vote tally or board announcement alone. Therefore, it is classified as AGM Information (AGM-R).
2026-05-27 Norwegian Bokmål
Arctic Bioscience - Notice of Annual General Meeting on 27 May 2026 - Attachment: 20260513_Arctic_Bioscience_AS_Notice_AGM_2026.pdf
Proxy Solicitation & Information Statement Classification · 85% confidence The document is the formal notice to shareholders of Arctic Bioscience AS of its annual general meeting, including the agenda, proposals (e.g. approval of accounts, election of board members, authorization for capital increase), voting instructions, proxy and advance vote procedures. It is sent to shareholders to provide information and solicit votes. This matches the definition of Proxy Solicitation & Information Statement (PSI), not the actual AGM presentations or the post-meeting voting results.
2026-05-13 Norwegian Bokmål
Arctic Bioscience - Innkalling til ordinær generalforsamling 27. mai 2026 - Attachment: 20260513_Arctic_Bioscience_AS_Notice_AGM_2026.pdf
Proxy Solicitation & Information Statement Classification · 96% confidence The document is the formal notice (‘Innkalling’) convening the company’s Annual General Meeting, setting out the agenda items (annual accounts, board elections, capital authorization, etc.) and providing detailed proxy and advance voting instructions. It is sent to shareholders to solicit proxies and inform them ahead of the meeting, rather than presenting the actual financial report or results. This matches our definition of Proxy Solicitation & Information Statement (PSI).
2026-05-13 Norwegian Bokmål

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.